Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Di Rocco · SciRah

Researcher profile · Semantic Scholar

A. Di Rocco

Share profile

A. Di Rocco — researcher profile on SciRah

h-index: 29
Works: 274
Citations: 3,100

Most-cited papers

Extranodal Marginal Zone Lymphoma: Pathogenesis, Diagnosis and Treatment
A. Di Rocco, L. Petrucci, G. Assanto, M. Martelli +1 more
2022Cancers68 citations Open access
Semantic Scholar
Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study
A. Chiappella, B. Casadei, P. Chiusolo, A. Di Rocco +28 more
2024Leukemia31 citations Open access
Semantic Scholar
Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results
Maurizio Martelli, L. Ceriani, G. Ciccone, U. Ricardi +44 more
2024Journal of Clinical Oncology30 citations Open access
Semantic Scholar
A Multicenter Real-life Prospective Study of Axicabtagene Ciloleucel versus Tisagenlecleucel Toxicity and Outcomes in Large B-cell Lymphomas
F. Stella, A. Chiappella, B. Casadei, S. Bramanti +26 more
2024Blood Cancer Discovery25 citations Open access
Semantic Scholar
Outcome after chimeric antigen receptor (CAR) T‐cell therapy failure in large B‐cell lymphomas
A. Dodero, S. Bramanti, M. di Trani, M. Pennisi +13 more
2023British Journal of Haematology23 citations Open access
Semantic Scholar
Molecular clustering on ctDNA improves the prognostic stratification of patients with DLBCL compared with ctDNA levels
R. Moia, D. Talotta, L. Terzi di Bergamo, M. Almasri +48 more
2025Blood Advances21 citations Open access
Semantic Scholar
Outcomes of younger patients with mantle-cell lymphoma experiencing late relapse (>24 months): the LATE-POD study.
C. Malinverni, A. Bernardelli, I. Glimelius, Massimo Mirandola +30 more
2024Blood20 citations
Semantic Scholar
Long-term follow-up of rituximab plus bendamustine and cytarabine in older patients with newly diagnosed MCL
M. Tisi, R. Moia, C. Patti, A. Evangelista +24 more
2023Blood Advances20 citations Open access
Semantic Scholar
Prospective Validation of CAR-HEMATOTOX and a simplified version predict Survival in Patients with Large B-Cell Lymphoma treated with anti-CD19 CAR T-cells: data from CART-SIE study.
F. Stella, M. Pennisi, A. Chiappella, B. Casadei +27 more
2025Transplantation and Cellular Therapy17 citations Open access
Semantic Scholar
Molecular measurable residual disease by immunoglobulin gene rearrangements on circulating tumor DNA predicts outcome in diffuse large B-cell lymphoma
R. Soscia, G. Assanto, I. Della Starza, R. Moia +11 more
2024Haematologica14 citations Open access
Semantic Scholar
A Fondazione Italiana Linfomi cohort study of R-COMP vs R-CHOP in older patients with diffuse large B-cell lymphoma
A. Arcari, L. Rigacci, A. Tucci, Benedetta Puccini +33 more
2023Blood Advances14 citations Open access
Semantic Scholar
Secondary primary malignancies after CD‐19 directed CAR‐T‐cell therapy in lymphomas: A report from the Italian CART‐SIE study
Angelica Barone, A. Chiappella, B. Casadei, S. Bramanti +15 more
2024British Journal of Haematology13 citations Open access
Semantic Scholar
Whole body MRI with Diffusion Weighted Imaging versus 18F-fluorodeoxyglucose-PET/CT in the staging of lymphomas
F. Maccioni, Giulia Alfieri, G. Assanto, M. Mattone +9 more
2023La radiologia medica13 citations Open access
Semantic Scholar
Primary mediastinal large B-cell Lymphoma: Biological features, clinical characteristics and current treatment strategies.
L. Donzelli, A. Di Rocco, L. Petrucci, Maurizio Martelli
2025Cancer Treatment Reviews12 citations
Semantic Scholar
Application of the Guidelines for the Integration of Photovoltaics in Historic Buildings and Landscapes to Evaluate the Best Practices of the Historic Building Energy Retrofit Atlas
A. Di Rocco, Dario Bottino-Leone, A. Troi, D. Herrera-Avellanosa
2024Buildings10 citations Open access
Semantic Scholar
Long-Term Host Immune Modulation Following Tisagenlecleucel Administration in Patients with Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemia
A. Guarini, G. Radice, N. Peragine, C. Buracchi +11 more
2023Cancers9 citations Open access
Semantic Scholar
Energy Poverty and Territorial Resilience: An Integrative Review and an Inclusive Governance Model
A. Di Rocco, M. R. Trovato, R. Caponetto, F. Nocera
2025Sustainability8 citations Open access
Semantic Scholar
Biological features and outcome of diffuse large B‐cell lymphoma associated with hepatitis C virus in elderly patients: Results of the prospective ‘Elderly Project’ by the Fondazione Italiana Linfomi
A. Arcari, V. Tabanelli, F. Merli, L. Marcheselli +21 more
2023British Journal of Haematology7 citations
Semantic Scholar
Case Report: Severe cutaneous adverse event associated with checkpoint inhibition in the setting of CAR T-cell therapy: beyond CRS
Chiara Masucci, S. Pepe, U. La Rocca, V. Zullino +7 more
2023Frontiers in Oncology7 citations Open access
Semantic Scholar
Long‐term results of the FIL MCL0208 trial of lenalidomide maintenance versus observation after ASCT in MCL patients
R. Tavarozzi, Simone Ferrero, A. Evangelista, E. Genuardi +27 more
2025HemaSphere6 citations Open access
Semantic Scholar
Impact of immunochemotherapy regimens on outcomes of patients with primary mediastinal B-cell lymphoma in the IELSG37 trial.
E. Zucca, L. Ceriani, G. Ciccone, A. Di Rocco +36 more
2025Blood6 citations
Semantic Scholar
Outcomes of CAR T-cell therapy in high-grade B-cell lymphomas compared to DLBCL: a weighted comparison analysis
A. Dodero, G. Ceparano, B. Casadei, P. Angelillo +20 more
2025Blood Advances6 citations Open access
Semantic Scholar
Rituximab, bendamustine, and cytarabine followed by venetoclax in older patients with high-risk mantle cell lymphoma (FIL_V-RBAC): a multicentre, single-arm, phase 2 study.
C. Visco, V. Tabanelli, M. Sacchi, A. Evangelista +39 more
2025The Lancet Haematology6 citations Open access
Semantic Scholar
Overcoming barriers to referral for CAR T-cell therapy in patients with non-Hodgkin aggressive B-cell lymphomas: A Delphi consensus.
S. Luminari, A. Chiappella, A. Di Rocco, L. Arcaini +8 more
2025Cytotherapy5 citations Open access
Semantic Scholar
Rituximab, Bendamustine and Cytarabine Followed By Venetoclax (V-RBAC) in High-Risk Older Patients with Mantle Cell Lymphoma: A Phase 2 Study By the Fondazione Italiana Linfomi (FIL)
C. Visco, V. Tabanelli, Mariana Sacchi, A. Evangelista +36 more
2023Blood5 citations
Semantic Scholar
Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the Fondazione Italiana Linfomi MCL0208 trial
S. Ferrero, Daniele Grimaldi, E. Arrigoni, Mariapia Pironti +24 more
2023Blood Advances5 citations Open access
Semantic Scholar
High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from Italy
M. Visentini, Andrea Pica, Giancarlo D’ippolito, Eleonora Sculco +11 more
2023Annals of Hematology5 citations Open access
Semantic Scholar
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023.
L. Ceriani, L. Milan, L. Cascione, A. Di Rocco +7 more
2023Hematological Oncology5 citations
Semantic Scholar
Comparative Effectiveness of R‐miniCOMP Versus R‐miniCHOP in Older Non‐Fit Patients With Diffuse Large B‐Cell Lymphoma: Insights From a “Fondazione Italiana Linfomi” Cohort Study
A. Bavieri, S. Usai, Michele Merli, A. Di Rocco +26 more
2025Hematological Oncology4 citations
Semantic Scholar
Routine prophylaxis with levetiracetam offers no benefit in CD19 CAR-T for LBCL: a multicenter propensity-matched study
E. Galli, R. Di Blasi, A. Di Rocco, C. Cristinelli +12 more
2025Blood Advances4 citations
Semantic Scholar
TP53, CD36 Mutations and CDKN2A Loss Predict Poor Outcome in Mantle Cell Lymphoma: Molecular Analysis of the FIL V-Rbac Phase 2 Trial
R. Moia, M. E. Carazzolo, C. Cosentino, M. Almasri +40 more
2024Blood4 citations
Semantic Scholar
Out of specification Tisagenlecleucel is associated with outcomes comparable to standard of care product in relapsed or refractory diffuse large B-cell lymphoma
C. De Philippis, Cristina Zucchinetti, D. Mannina, M. Krampera +9 more
2024Bone Marrow Transplantation4 citations Open access
Semantic Scholar
Systemic inflammation and CAR-T specific toxicities as major drivers of non-relapse mortality: analysis from the Italian prospective observational CART-SIE Study.
Angelica Barone, Federico Stella, S. Ljevar, B. Casadei +27 more
2026Transplantation and Cellular Therapy3 citations Open access
Semantic Scholar
Managing Treatment‐Emergent Immune Effector Cell‐Associated Hemophagocytic Lymphohistiocytosis‐Like Syndrome Following CAR‐T Cell Therapy: A Case‐Based Review of the use of Emapalumab
L. Donzelli, V. Zullino, Giovanni F. Torelli, M. D. De Propris +4 more
2025Hematological Oncology3 citations Open access
Semantic Scholar
A RANDOMIZED TRIAL OF OBSERVATION VERSUS RADIOTHERAPY IN PRIMARY MEDIASTINAL B‐CELL LYMPHOMA PATIENTS WITH COMPLETE METABOLIC RESPONSE AFTER STANDARD IMMUNOCHEMOTHERAPY
A. Davies, E. Zucca, L. Ceriani, I. Kryachok +40 more
2023Hematological Oncology3 citations Open access
Semantic Scholar
MOLECULAR CLUSTERING ON CTDNA IMPROVES THE PROGNOSTIC STRATIFICATION OF DLBCL PATIENTS COMPARED TO CTDNA LEVELS
R. Moia, D. Talotta, R. Dondolin, M. Almasri +32 more
2023Hematological Oncology3 citations Open access
Semantic Scholar
Siltuximab as a first-line therapy for idiopathic multicentric Castleman disease: a retrospective analysis based on the SiMuLa study of the Italian regional network
S. Pelliccia, A. Di Rocco, G. Palumbo, A. Zizzari +14 more
2026Frontiers in Oncology2 citations
Semantic Scholar
PET-guided early identification of CAR-T candidates in diffuse large b-cell lymphoma: a multidisciplinary expert consensus
L. Guerra, D. Albano, P. Angelillo, A. Di Rocco +5 more
2026European Journal of Nuclear Medicine and Molecular Imaging2 citations Open access
Semantic Scholar
The integration of gene mutations and copy number variations refines the prognosis of mantle cell lymphoma: long-term results of the Fondazione Italiana Linfomi MCL0208 clinical trial
R. Moia, S. Ragaini, L. Cascione, Andrea Rinaldi +28 more
2025Leukemia2 citations Open access
Semantic Scholar
Health-related quality of life trajectories of patients with aggressive B-cell lymphomas treated with CAR T-cell therapy: Results from a prospective observational study
F. Efficace, F. Bonifazi, P. Zinzani, I. Cutini +16 more
2025Blood2 citations
Semantic Scholar
PET-Based Prognostic Stratification in Primary Mediastinal B-Cell Lymphoma Using the SUV≥4 Segmentation Threshold: A Comparative Analysis of Contouring Methods in the IELSG37 Trial Cohort
L. Ceriani, L. Milan, M. Pirosa, A. Di Rocco +6 more
2024Blood2 citations
Semantic Scholar
Lymphocyte recovery after bendamustine therapy in patients with mantle cell lymphoma. Results of a retrospective analysis and prognostic impact in the CAR-T era
L. Donzelli, M. Antonacci, N. Zhdanovskaya, L. Petrucci +3 more
2024Annals of Hematology2 citations
Semantic Scholar
A SWOT‐Consensus for CAR‐T in Follicular Lymphoma: Fine Tuning of Patient Journey and Selection
M. Marchetti, P. Corradini, L. Arcaini, S. Bramanti +5 more
2024Hematological Oncology2 citations Open access
Semantic Scholar
Health-Related Quality of Life Profile and Symptom Burden of Patients with Aggressive B-Cell Lymphomas Just before CAR-T-Cell Therapy: A Real-World Study By the Gimema
F. Efficace, P. Zinzani, F. Bonifazi, M. Clerico +17 more
2023Blood2 citations Open access
Semantic Scholar
Survival Patterns of Non-Randomized Patients in the IELSG37 Study: Deauville Score 4 Is Not Necessarily Associated with Poor Outcome in Primary Mediastinal Lymphoma
E. Zucca, L. Ceriani, Andrew S. Davies, G. Ciccone +47 more
2023Blood2 citations
Semantic Scholar
The Italian CART‐SIE real life multicenter observational study on Chimeric Antigen Receptor T‐cell (CAR‐T) therapy for large B‐cell (LBCL) and mantle cell (MCL) lymphomas
A. Chiappella, A. Dodero, S. Ljevar, M. Pennisi +25 more
2023Hematological Oncology2 citations Open access
Semantic Scholar
Impact of SARS-CoV-2 vaccination and passive prophylaxis with tixagevimab/cilgavimab on CAR-T patients: a three-year regional experience from the Italian covid pandemic
E. Galli, A. Di Rocco, Ilaria Pansini, F. Frondizi +12 more
2023Bone Marrow Transplantation2 citations
Semantic Scholar
Efficacy of Residual Site Radiation Therapy (ISRT) in Patients with Primary Mediastinal Lymphoma with Deauville Score 4 Following R-CHT: Results of a Retrospective Mono Institutional Study
G. Facondo, Mattia Serio, G. Vullo, M. Bianchi +9 more
2023Journal of Clinical Medicine2 citations Open access
Semantic Scholar
[CAR-T cell immunotherapy in early relapse after introduction chemoimmunotherapy.]
L. Donzelli, A. Di Rocco
2026Recenti progressi in medicina1 citations
Semantic Scholar
Polatuzumab vedotin–containing regimens as bridge to CART: analysis from the CART-SIE study
Giulia Gabrielli, B. Casadei, A. Chiappella, M. Tisi +22 more
2026Blood Advances1 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Tisi×16
Invite
M. Tisi — researcher profile on SciRah
P. Zinzani×13
Invite
P. Zinzani — researcher profile on SciRah
V. Zilioli×13
Invite
V. Zilioli — researcher profile on SciRah
A. Chiappella×11
Invite
A. Chiappella — researcher profile on SciRah

×11

Invite

S. Bramanti — researcher profile on SciRah

P. Corradini×11

Invite

P. Corradini — researcher profile on SciRah

M. Balzarotti×11

Invite

M. Balzarotti — researcher profile on SciRah

Invite

F. Merli — researcher profile on SciRah

Maurizio Martelli×10

Invite

Maurizio Martelli — researcher profile on SciRah

Benedetta Puccini×10

Invite

Benedetta Puccini — researcher profile on SciRah

Invite

L. Petrucci — researcher profile on SciRah

Invite

B. Botto — researcher profile on SciRah